Literature DB >> 34115979

Low back pain.

Nebojsa Nick Knezevic1, Kenneth D Candido2, Johan W S Vlaeyen3, Jan Van Zundert4, Steven P Cohen5.   

Abstract

Low back pain covers a spectrum of different types of pain (eg, nociceptive, neuropathic and nociplastic, or non-specific) that frequently overlap. The elements comprising the lumbar spine (eg, soft tissue, vertebrae, zygapophyseal and sacroiliac joints, intervertebral discs, and neurovascular structures) are prone to different stressors, and each of these, alone or in combination, can contribute to low back pain. Due to numerous factors related to low back pain, and the low specificity of imaging and diagnostic injections, diagnostic methods for this condition continue to be a subject of controversy. The biopsychosocial model posits low back pain to be a dynamic interaction between social, psychological, and biological factors that can both predispose to and result from injury, and should be considered when devising interdisciplinary treatment plans. Prevention of low back pain is recognised as a pivotal challenge in high-risk populations to help tackle high health-care costs related to therapy and rehabilitation. To a large extent, therapy depends on pain classification, and usually starts with self-care and pharmacotherapy in combination with non-pharmacological methods, such as physical therapies and psychological treatments in appropriate patients. For refractory low back pain, a wide range of non-surgical (eg, epidural steroid injections and spinal cord stimulation for neuropathic pain, and radiofrequency ablation and intra-articular steroid injections for mechanical pain) and surgical (eg, decompression for neuropathic pain, disc replacement, and fusion for mechanical causes) treatment options are available in carefully selected patients. Most treatment options address only single, solitary causes and given the complex nature of low back pain, a multimodal interdisciplinary approach is necessary. Although globally recognised as an important health and socioeconomic challenge with an expected increase in prevalence, low back pain continues to have tremendous potential for improvement in both diagnostic and therapeutic aspects. Future research on low back pain should focus on improving the accuracy and objectivity of diagnostic assessments, and devising treatment algorithms that consider unique biological, psychological, and social factors. High-quality comparative-effectiveness and randomised controlled trials with longer follow-up periods that aim to establish the efficacy and cost-effectiveness of low back pain management are warranted.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 34115979     DOI: 10.1016/S0140-6736(21)00733-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

1.  Epidemiological trends of low back pain at the global, regional, and national levels.

Authors:  Linfeng Wang; Hong Ye; Zhichao Li; Chengwu Lu; Jian Ye; Mingxin Liao; Xiaojie Chen
Journal:  Eur Spine J       Date:  2022-02-26       Impact factor: 3.134

2.  Magnetic therapy in acute and subacute non-specific back pain: Results of an open multicenter study.

Authors:  Andrey Karateev; Elena Polishchuk; Anatoly Fesyun; Tatiana Konchugova; Ekaterina Filatova; Vera Amirdzhanova; Detelina Kulchitskaya; Alena Potapova; Marina Sukhareva; Alexander Lila; Elena P Ivanova
Journal:  Eur J Transl Myol       Date:  2022-07-29

3.  Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial.

Authors:  Matthew K Bagg; Benedict M Wand; Aidan G Cashin; Hopin Lee; Markus Hübscher; Tasha R Stanton; Neil E O'Connell; Edel T O'Hagan; Rodrigo R N Rizzo; Michael A Wewege; Martin Rabey; Stephen Goodall; Sopany Saing; Serigne N Lo; Hannu Luomajoki; Robert D Herbert; Chris G Maher; G Lorimer Moseley; James H McAuley
Journal:  JAMA       Date:  2022-08-02       Impact factor: 157.335

4.  Smoking, alcohol and coffee consumption and risk of low back pain: a Mendelian randomization study.

Authors:  Zhengtao Lv; Jiarui Cui; Jiaming Zhang
Journal:  Eur Spine J       Date:  2022-09-16       Impact factor: 2.721

5.  Provider-patient communication: an illustrative case report of how provider language can influence patient prognosis.

Authors:  Kelsey Pierce; Alyssa Troutner; Lindsay Rae; Janet Austin
Journal:  J Can Chiropr Assoc       Date:  2022-04

6.  Self-amplifying loop of NF-κB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration.

Authors:  Jinna Wu; Yuyu Chen; Zhiheng Liao; Hengyu Liu; Shun Zhang; Dongmei Zhong; Xianjian Qiu; Taiqiu Chen; Deying Su; Xiaona Ke; Yong Wan; Taifeng Zhou; Peiqiang Su
Journal:  Mol Ther       Date:  2022-05-26       Impact factor: 12.910

7.  The use of platelet-rich plasma in management of musculoskeletal pain: a narrative review.

Authors:  Aung Chan Thu
Journal:  J Yeungnam Med Sci       Date:  2022-06-08

8.  Non-surgical therapy for the treatment of chronic low back pain in patients with Modic changes: A systematic review of the literature.

Authors:  Xiaoping Mu; Wei Peng; Yufu Ou; Peifeng Li; Zhuhai Li; Jianxun Wei
Journal:  Heliyon       Date:  2022-06-30

Review 9.  New Progress in Basic Research of Macrophages in the Pathogenesis and Treatment of Low Back Pain.

Authors:  Miaoheng Yan; Zongmian Song; Hongwei Kou; Guowei Shang; Chunfeng Shang; Xiangrong Chen; Yanhui Ji; Deming Bao; Tian Cheng; Jinfeng Li; Xiao Lv; Hongjian Liu; Songfeng Chen
Journal:  Front Cell Dev Biol       Date:  2022-05-20

Review 10.  Precision medicine strategies for spinal degenerative diseases: Injectable biomaterials with in situ repair and regeneration.

Authors:  Xiaoming Zhao; Hongyun Ma; Hao Han; Liuyang Zhang; Jing Tian; Bo Lei; Yingang Zhang
Journal:  Mater Today Bio       Date:  2022-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.